✦ LIBER ✦

Pharmacogenomic biomarkers in cardiovascular medicinal product development

✍ Scribed by Novelli, Giuseppe

Book ID: 123241676
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 121 KB
Volume: 46
Category: Article
ISSN: 0009-9120
DOI: 10.1016/j.clinbiochem.2013.05.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenomics in Cardiovascular Medic

Pharmacogenomics in Cardiovascular Medicine

✍ John F. Carlquist; Jeffrey L. Anderson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Applied Pharmacogenomics in Cardiovascul

Applied Pharmacogenomics in Cardiovascular Medicine

✍ Weeke, Peter; Roden, Dan M. 📂 Article 📅 2014 🏛 Annual Reviews 🌐 English ⚖ 371 KB

Biomarkers in Cardiovascular Medicine

✍ José L. Martín-Ventura; Luis M. Blanco-Colio; José Tuñón; Begoña Muñoz-García; J 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Current Role of Pharmacogenomics in Card

Current Role of Pharmacogenomics in Cardiovascular Medicine

✍ Kiran Musunuru 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 138 KB

[Methods in Pharmacology and Toxicology]

[Methods in Pharmacology and Toxicology] Pharmacogenomics and Personalized Medicine || Pharmacogenomics and Cardiovascular Drugs

✍ Cohen, Nadine 📂 Article 📅 2008 🏛 Humana Press ⚖ 876 KB

Genomic and Personalized Medicine || Pha

Genomic and Personalized Medicine || Pharmacogenomics in Drug Discovery and Development

✍ Johnson, Keith J. (author);Eck, Stephen L. (author) 📂 Article 📅 2013 🏛 Elsevier Inc. 🌐 English ⚖ 686 KB

With advancing knowledge of the genome across and outside protein-coding regions of DNA, new comprehension of genomic variation and frequencies across populations, the elucidation of advanced strategic approaches to genomic study, and above all in the elaboration of next-generation sequencing, genom